{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T04:44:19Z","timestamp":1785905059982,"version":"3.56.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004035","name":"Jordan University of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019004","name":"Jordan University of Science and Technology Deanship of Research","doi-asserted-by":"publisher","award":["414\/2024"],"award-info":[{"award-number":["414\/2024"]}],"id":[{"id":"10.13039\/501100019004","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jdiacomp.2026.109362","type":"journal-article","created":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T14:38:05Z","timestamp":1782052685000},"page":"109362","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of the protective effects of liraglutide, dapagliflozin and their combination in rat kidneys of streptozotocin induced diabetes"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2086-7205","authenticated-orcid":false,"given":"Fadia","family":"Mayyas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdiacomp.2026.109362_bb0005","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2020-001847","article-title":"Prevalence and incidence of microvascular and macrovascular complications over 15 years among patients with incident type 2 diabetes","volume":"9","author":"An","year":"2021","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.jdiacomp.2026.109362_bb0010","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jfma.2018.02.007","article-title":"Update of pathophysiology and management of diabetic kidney disease","volume":"117","author":"Lin","year":"2018","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jdiacomp.2026.109362_bb0015","doi-asserted-by":"crossref","first-page":"248","DOI":"10.2337\/dbi18-0007","article-title":"Sodium-Glucose Cotransporter 2 Inhibition and Diabetic Kidney Disease","volume":"68","author":"Alicic","year":"2019","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2026.109362_bb0020","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S2213-8587(19)30249-9","article-title":"Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials","volume":"7","author":"Kristensen","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jdiacomp.2026.109362_bb0025","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejphar.2016.08.022","article-title":"Mechanistic insight of diabetic nephropathy and its pharmacotherapeutic targets: An update","volume":"791","author":"Bhattacharjee","year":"2016","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jdiacomp.2026.109362_bb0030","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.biopha.2016.06.004","article-title":"Effect of resveratrol and rosuvastatin on experimental diabetic nephropathy in rats","volume":"82","author":"Hussein","year":"2016","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jdiacomp.2026.109362_bb0035","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/MNH.0000000000000185","article-title":"Endothelin-1 and the kidney: new perspectives and recent findings","volume":"25","author":"De Miguel","year":"2016","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.jdiacomp.2026.109362_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.semnephrol.2023.151431","article-title":"Role of Inflammation in Progression of Chronic Kidney Disease in Type 2 Diabetes Mellitus: Clinical Implications","volume":"43","author":"Oda","year":"2023","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.jdiacomp.2026.109362_bb0045","article-title":"Signaling Pathways Involved in Diabetic Renal Fibrosis","volume":"9","author":"Zhang","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.jdiacomp.2026.109362_bb0050","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.2215\/CJN.11491116","article-title":"Diabetic Kidney Disease: Challenges, Progress, and Possibilities","volume":"12","author":"Alicic","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jdiacomp.2026.109362_bb0055","article-title":"TGF-beta1 Signaling: Immune Dynamics of Chronic Kidney Diseases","volume":"8","author":"Tang","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jdiacomp.2026.109362_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114983","article-title":"Research progress on the role of PDGF\/PDGFR in type 2 diabetes","volume":"164","author":"Cao","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jdiacomp.2026.109362_bb0065","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1172\/JCI114734","article-title":"Abnormal cardiac function in the streptozotocin-diabetic rat. Changes in active and passive properties of the left ventricle","volume":"86","author":"Litwin","year":"1990","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jdiacomp.2026.109362_bb0070","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.atherosclerosis.2015.03.026","article-title":"GLP-1 analog liraglutide protects against cardiac steatosis, oxidative stress and apoptosis in streptozotocin-induced diabetic rats","volume":"240","author":"Inoue","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jdiacomp.2026.109362_bb0075","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1161\/CIRCULATIONAHA.118.038868","article-title":"Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus","volume":"139","author":"Zelniker","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jdiacomp.2026.109362_bb0080","doi-asserted-by":"crossref","first-page":"967","DOI":"10.3389\/fphar.2020.00967","article-title":"GLP-1 Receptor Agonists in Diabetic Kidney Disease: From Clinical Outcomes to Mechanisms","volume":"11","author":"Kawanami","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jdiacomp.2026.109362_bb0085","first-page":"5622","article-title":"The promising significance of liraglutide combined with dapagliflozin or empagliflozin in the prevention of early diabetic nephropathy","volume":"14","author":"Li","year":"2022","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.jdiacomp.2026.109362_bb0090","doi-asserted-by":"crossref","first-page":"42390","DOI":"10.1007\/s11356-023-25254-8","article-title":"Protective effect of quercetin on pulmonary dysfunction in streptozotocin-induced diabetic rats via inhibition of NLRP3 signaling pathway","volume":"30","author":"El-Shaer","year":"2023","journal-title":"Environ Sci Pollut Res"},{"key":"10.1016\/j.jdiacomp.2026.109362_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119018","article-title":"Role of sodium glucose cotransporter type 2 inhibitors dapagliflozin on diabetic nephropathy in rats; Inflammation, angiogenesis and apoptosis","volume":"280","author":"Elkazzaz","year":"2021","journal-title":"Life Sci"},{"key":"10.1016\/j.jdiacomp.2026.109362_bb0100","article-title":"Liraglutide protects cardiac function in diabetic rats through the PPAR\u03b1 pathway","volume":"38","author":"Zhang","year":"2018","journal-title":"Biosci Rep"},{"key":"10.1016\/j.jdiacomp.2026.109362_bb0105","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13098-026-02094-3","article-title":"Acute renoprotective effects of dapagliflozin monotherapy on albuminuria and metabolic derangements in newly diagnosed type 2 diabetes mellitus: a quasi-experimental study","volume":"18","author":"Eghreib","year":"2026","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/j.jdiacomp.2026.109362_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2025.152176","article-title":"Sex-specific differences in glucose metabolism and pancreatic function in streptozotocin-induced diabetic mice: The protective role of estrogen","volume":"775","author":"Kim","year":"2025","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jdiacomp.2026.109362_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2025.123721","article-title":"Comparison of the cardioprotective effects of liraglutide, dapagliflozin and their combination in a rat model of diabetes induced by streptozotocin","volume":"375","author":"Mayyas","year":"2025","journal-title":"Life Sci"},{"key":"10.1016\/j.jdiacomp.2026.109362_bb0125","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2025.1602594","article-title":"Immune inflammation and metabolic interactions in the pathogenesis of diabetic nephropathy","volume":"16","author":"Hou","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jdiacomp.2026.109362_bb0130","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1111\/dom.16366","article-title":"The effect of GLP-1 receptor agonists on circulating inflammatory markers in type 2 diabetes patients: A systematic review and meta-analysis","volume":"27","author":"Ren","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jdiacomp.2026.109362_bb0135","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s12020-015-0852-y","article-title":"Effects of glucagon-like peptide-1 on advanced glycation endproduct-induced aortic endothelial dysfunction in streptozotocin-induced diabetic rats: possible roles of Rho kinase- and AMP kinase-mediated nuclear factor \u03baB signaling pathways","volume":"53","author":"Tang","year":"2016","journal-title":"Endocrine"},{"key":"10.1016\/j.jdiacomp.2026.109362_bb0140","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1111\/dom.13301","article-title":"Effects of the SGLT-2 inhibitor dapagliflozin on glomerular and tubular injury markers","volume":"20","author":"Dekkers","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jdiacomp.2026.109362_bb0145","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s00395-007-0673-0","article-title":"Tumor necrosis factor-alpha antagonism protects from myocardial inflammation and fibrosis in experimental diabetic cardiomyopathy","volume":"102","author":"Westermann","year":"2007","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.jdiacomp.2026.109362_bb0150","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00018-022-04289-z","article-title":"Anti-inflammatory effect of SGLT-2 inhibitors via uric acid and insulin","volume":"79","author":"La Grotta","year":"2022","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jdiacomp.2026.109362_bb0155","first-page":"191","article-title":"Tofogliflozin, A Highly Selective Inhibitor of SGLT2 Blocks Proinflammatory and Proapoptotic Effects of Glucose Overload on Proximal Tubular Cells Partly by Suppressing Oxidative Stress Generation","volume":"48","author":"Ishibashi","year":"2016","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.jdiacomp.2026.109362_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph20176671","article-title":"Immunomodulatory Effects of SGLT2 Inhibitors-Targeting Inflammation and Oxidative Stress in Aging","volume":"20","author":"Sch\u00f6nberger","year":"2023","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.jdiacomp.2026.109362_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2012.02.011","article-title":"SOD1 suppresses maternal hyperglycemia-increased iNOS expression and consequent nitrosative stress in diabetic embryopathy","volume":"206","author":"Weng","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jdiacomp.2026.109362_bb0170","article-title":"Glucagon-Like Peptide-1 Mediates the Protective Effect of the Dipeptidyl Peptidase IV Inhibitor on Renal Fibrosis via Reducing the Phenotypic Conversion of Renal Microvascular Cells in Monocrotaline-Treated Rats","volume":"2018","author":"Xu","year":"2018","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jdiacomp.2026.109362_bb0175","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15030965","article-title":"SGLT2 Inhibitor-Dapagliflozin Attenuates Diabetes-Induced Renal Injury by Regulating Inflammation through a CYP4A\/20-HETE Signaling Mechanism","volume":"15","author":"Dia","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jdiacomp.2026.109362_bb0180","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-19988-7","article-title":"SGLT2 inhibitors attenuate nephrin loss and enhance TGF-\u03b2(1) secretion in type 2 diabetes patients with albuminuria: a randomized clinical trial","volume":"12","author":"Tian","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.jdiacomp.2026.109362_bb0185","doi-asserted-by":"crossref","first-page":"F317","DOI":"10.1152\/ajprenal.00145.2014","article-title":"The SGLT2 inhibitor empagliflozin ameliorates early features of diabetic nephropathy in BTBR ob\/ob type 2 diabetic mice with and without hypertension","volume":"307","author":"Gembardt","year":"2014","journal-title":"Am J Physiol Ren Physiol"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872726001078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872726001078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T03:49:08Z","timestamp":1785901748000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872726001078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1056872726001078"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2026.109362","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the protective effects of liraglutide, dapagliflozin and their combination in rat kidneys of streptozotocin induced diabetes","name":"articletitle","label":"Article Title"},{"value":"Journal of Diabetes and its Complications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2026.109362","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109362"}}